Posts Tagged ‘Knight Cancer Institute’

New treatment may address imatinib-resistant tumors

Each year, 3,000 to 6,000 people are diagnosed with gastrointestinal stromal tumor (GIST)—the most common sarcoma of the gastrointestinal tract. Imatinib myeslate, or Gleevec®, has proved to be a highly effective therapy for many patients with GIST, although long-term survival is poor due to the development of imatinib-resistant GIST mutation types. Research recently published in Science Translational Medicine demonstrated promising results for a new treatment, BLU-285, which specifically targets two of the most common imatinib-resistant GIST mutations: KIT … Read More

Renowned scientist to lead precision oncology for the OHSU Knight Cancer Institute

Internationally renowned scientist Gordon B. Mills, M.D., Ph.D., is joining OHSU to lead precision oncology for the Knight Cancer Institute. One of the most highly cited medical scientists in the world, Mills will bring a breadth of research and leadership experience to OHSU. He was recruited from the MD Anderson Cancer Center in Houston, where he has been a clinical and research leader since 1994. At OHSU, Mills will integrate research across multiple areas, including early … Read More

2017 Biomedical Innovation Program Drug Discovery awards announced

Two drug discovery projects have been named recipients of the 2017 Biomedical Innovation Program awards. The awards program is a collaboration of the Oregon Clinical & Translational Research Institute, OHSU Technology Transfer & Business Development, and the Knight Cancer Institute. The awards provide funds, project management, and mentorship to facilitate the development of innovative technologies at OHSU and accelerate their translation to the marketplace. This track of funding supports drug discovery platforms and early stage … Read More

OHSU breaks ground on cancer research facility

OHSU broke ground June 16 on its newest building, the 320,000-square-foot Knight Cancer Institute research facility on the South Waterfront. Located north of the Collaborative Life Sciences Building, the new facility will house up to 600 researchers and administrators dedicated to research programs in early cancer detection, computational biology, immuno-oncology, leukemia, prostate, and other areas. Construction is slated to be complete in July 2018. Visit the OHSU news website and the Knight News blog for … Read More

Marquam Hill Lecture: Transforming cancer care with next-gen. sequencing, May 19

The 2016 Marquam Hill Lecture Series continues this month with Christopher Corless, M.D., Ph.D., professor of pathology in the School of Medicine and chief medical officer of OHSU’s Knight Diagnostic Laboratories, presenting “Transforming cancer care with next-generation sequencing.” Marquam Hill Lecture Thursday, Mar. 19 7 p.m. OHSU Auditorium About the lecture New technology gives researchers mountains of data about DNA mutations and how they cause cancer, but how can this information be turned into the right therapy for … Read More

Join the fight against skin cancer, May 21

In a state more known for rain than sunshine, one would think skin cancer wouldn’t be much of a concern in Oregon. The fact is, Oregon ranks fifth in the nation for melanoma, the most serious of all skin cancers. Researchers at OHSU are on the case, declaring war on melanoma and engaging patients, survivors and the community to figure out how best to prevent, treat and detect the disease. Sancy Leachman, M.D., Ph.D., director … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives